Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4

3(60.0%)

N/A

2(40.0%)

5Total

Phase 4(3)

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT00533468Phase 4Completed

"Lidocaine 4% Cream (LMX4) vs Placebo for Pain Due to Lumbar Puncture in Infants 0-60 Days of Age."

Role: collaborator

NCT01746056Not ApplicableCompleted

A Comparative Study of Occlusive Heat Patch in the Treatment of Warts

Role: collaborator

NCT01910831Phase 4Completed

Study to Assess DerMend Moisturizing Bruise Formula in Improving the Appearance of Chronically Aged Forearms and Hands

Role: collaborator

NCT03167515Not ApplicableCompleted

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

Role: lead

NCT00847093Phase 4Completed

LMX-4 for Postoperative Pain Management in Infants and Children Undergoing Penoplasty Surgery

Role: lead

All 5 trials loaded